XGN vs. RGS
XGN (Exagen Inc.) and RGS (Regis Corporation) are both stocks. XGN operates in Diagnostics & Research (Healthcare), while RGS operates in Personal Services (Consumer Cyclical). Over the past 5 years, XGN returned -17.59%/yr vs -29.69%/yr for RGS. Their 0.15 correlation means their historical movements had little consistent relationship.
Performance
XGN vs. RGS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XGN achieves a -25.49% return, which is significantly lower than RGS's -1.33% return.
XGN
- 1D
- -3.00%
- 1M
- -0.22%
- 6M
- 23.10%
- YTD
- -25.49%
- 1Y
- -47.51%
- 3Y*
- 21.91%
- 5Y*
- -17.59%
- 10Y*
- —
- ALL TIME*
- -17.38%
RGS
- 1D
- -0.18%
- 1M
- 1.03%
- 6M
- 21.37%
- YTD
- -1.33%
- 1Y
- 44.68%
- 3Y*
- -0.02%
- 5Y*
- -29.69%
- 10Y*
- -20.06%
- ALL TIME*
- -3.48%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $177.25K | $165.72K | $196.25K | |
XGN Exagen Inc. | $1.07M | $1.02M | $1.70M |
XGN vs. RGS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XGN Exagen Inc. | -25.49% | 48.29% | 106.03% | -17.08% | -79.36% | -11.89% | -48.03% | 51.19% |
RGS Regis Corporation | -1.33% | 16.99% | 151.01% | -61.27% | -29.89% | -81.07% | -48.57% | -7.60% |
Correlation
The correlation between XGN and RGS is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.10 |
Correlation (All Time) Calculated using the full available price history since Sep 19, 2019 | 0.15 |
The correlation between XGN and RGS shifts across timeframes, from 0.05 (3 years) to 0.15 (all time), reflecting how their relationship changes across market environments.
Fundamentals
XGN:
$109.44M
RGS:
$68.42M
XGN:
-$0.89
RGS:
$39.69
XGN:
1.51
RGS:
0.34
XGN:
7.49
RGS:
0.41
XGN:
$68.38M
RGS:
$228.88M
XGN:
$39.88M
RGS:
$138.74M
XGN:
-$15.91M
RGS:
$22.14M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGN vs. RGS — Risk / Return Rank
XGN
RGS
XGN vs. RGS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Exagen Inc. (XGN) and Regis Corporation (RGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XGN | RGS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.68 | ||
| Sortino ratioReturn per unit of downside risk | -2.59 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.21 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 1.27 | -1.86 |
| Martin ratioReturn relative to average drawdown | -0.86 | 3.20 | -4.06 |
Loading charts...
Drawdowns
XGN vs. RGS - Drawdown Comparison
The maximum XGN drawdown since its inception was -95.22%, roughly equal to the maximum RGS drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for XGN and RGS.
Loading charts...
Drawdown Indicators
| XGN | RGS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.22% | -99.52% | +4.30% |
Max Drawdown (1Y)Largest decline over 1 year | -77.84% | -36.77% | -41.07% |
Max Drawdown (3Y)Largest decline over 3 years | -77.84% | -83.79% | +5.95% |
Max Drawdown (5Y)Largest decline over 5 years | -90.58% | -97.36% | +6.78% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.10% | — |
Current DrawdownCurrent decline from peak | -84.09% | -96.82% | +12.73% |
Average DrawdownAverage peak-to-trough decline | -71.09% | -47.97% | -23.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.41% | 14.54% | +38.87% |
Volatility
XGN vs. RGS - Volatility Comparison
Exagen Inc. (XGN) has a higher volatility of 23.42% compared to Regis Corporation (RGS) at 9.60%. This indicates that XGN's price experiences larger fluctuations and is considered to be riskier than RGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGN | RGS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.42% | 9.60% | +13.82% |
Volatility (6M)Calculated over the trailing 6-month period | 60.11% | 30.81% | +29.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.60% | 45.13% | +26.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.50% | 165.20% | -81.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 88.27% | 124.50% | -36.23% |
Dividends
XGN vs. RGS - Dividend Comparison
Neither XGN nor RGS has paid dividends to shareholders.
Financials
XGN vs. RGS - Financials Comparison
This section allows you to compare key financial metrics between Exagen Inc. and Regis Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XGN vs. RGS - Profitability Comparison
XGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Exagen Inc. reported a gross profit of 10.21M and revenue of 17.31M. Therefore, the gross margin over that period was 59.0%.
RGS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Regis Corporation reported a gross profit of 48.79M and revenue of 52.41M. Therefore, the gross margin over that period was 93.1%.
XGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Exagen Inc. reported an operating income of -3.41M and revenue of 17.31M, resulting in an operating margin of -19.7%.
RGS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Regis Corporation reported an operating income of 5.72M and revenue of 52.41M, resulting in an operating margin of 10.9%.
XGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Exagen Inc. reported a net income of -3.97M and revenue of 17.31M, resulting in a net margin of -22.9%.
RGS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Regis Corporation reported a net income of 735.00K and revenue of 52.41M, resulting in a net margin of 1.4%.
Frequently Asked Questions
XGN and RGS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XGN has higher volatility (23.42%) compared to RGS (9.60%). In terms of maximum drawdown, XGN dropped -95.22% vs RGS's -99.52%.
RGS currently has the higher Sharpe Ratio (1.04 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XGN and RGS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer